Laboratory Testing for a 15-Year-Old with TSH 8 mIU/L
Immediately order a repeat TSH with free T4 (FT4) to confirm the elevation, and measure anti-thyroid peroxidase (anti-TPO) antibodies to identify autoimmune etiology. 1
Initial Confirmatory Testing
The first step is confirmation because TSH levels are highly variable and a single elevated value does not establish persistent thyroid dysfunction 1, 2:
- Repeat TSH with free T4 at minimum 2 weeks but no longer than 3 months after the initial test 1
- Anti-TPO antibodies to identify autoimmune thyroiditis (Hashimoto's disease), which is the most common cause in adolescents 1, 3
The TSH of 8 mIU/L falls in the 4.5-10 mIU/L range, defining mild subclinical hypothyroidism 1, 3. At this level, TSH elevation may be transient—studies show poor reproducibility of mildly elevated TSH values, with an initial TSH of 5 having only 14% specificity for remaining elevated on repeat testing 4.
Why These Specific Tests
Free T4 (FT4)
- Confirms whether this is truly subclinical hypothyroidism (normal FT4) versus overt hypothyroidism (low FT4) 1, 2
- If FT4 is below the reference range (0.8-2.0 ng/dL), thyroid hormone therapy is indicated regardless of TSH level 1
- FT4 is superior to total T4 because it is not affected by binding protein variations 5
Anti-TPO Antibodies
- Identifies autoimmune etiology (Hashimoto's thyroiditis), the predominant cause in adolescents 1, 3
- Predicts higher risk of progression to overt hypothyroidism: 4.3% per year in antibody-positive versus 2.6% per year in antibody-negative individuals 1
- While antibody status doesn't change the diagnosis of subclinical hypothyroidism, it informs prognosis and monitoring frequency 1, 4
Additional Clinical Assessment
While awaiting repeat labs, evaluate for:
- Symptoms of hypothyroidism: fatigue, cold intolerance, weight gain, constipation, dry skin, hair loss 2, 3
- Thyroid gland examination: palpate for goiter or nodules 1, 4
- Growth parameters: height, weight, growth velocity (critical in adolescents) 3
- Family history: thyroid disease or autoimmune disorders 1
- Medication history: lithium, amiodarone, or other drugs affecting thyroid function 1
What NOT to Order Initially
- T3 or free T3: Not indicated in hypothyroidism evaluation; only useful when TSH is suppressed and hyperthyroidism is suspected 5, 6
- Thyroid ultrasound: Not routinely needed unless goiter or nodules are palpated 7, 6
- Thyroglobulin: Not useful in primary hypothyroidism evaluation 6
Management Based on Confirmatory Results
If Repeat TSH Remains 4.5-10 mIU/L with Normal FT4:
- Do NOT routinely initiate levothyroxine treatment 1
- Repeat thyroid function tests every 6-12 months to monitor for progression 1
- Consider treatment trial only if clearly symptomatic, but evidence for benefit is weak in this TSH range 1
If Repeat TSH >10 mIU/L with Normal FT4:
- Levothyroxine therapy is reasonable given higher progression risk (5% annually) 1
- Treatment threshold of TSH >10 mIU/L is based on expert consensus and higher likelihood of clinical benefit 2, 3
If FT4 is Low (Overt Hypothyroidism):
- Initiate levothyroxine immediately regardless of TSH level 1
Critical Pitfalls to Avoid
- Acting on a single TSH value: TSH secretion is highly sensitive to acute illness, stress, medications, and has significant intra-individual variability 2, 4
- Overtreatment of mild TSH elevations: 14-21% of patients treated with levothyroxine develop iatrogenic subclinical hyperthyroidism 1
- Assuming symptoms are thyroid-related: Fatigue, weight changes, and other nonspecific symptoms are common in adolescents and poorly correlate with TSH levels of 4.5-10 mIU/L 1, 7
- Unnecessary referral to endocrinology: TSH levels slightly above reference range without other clinical concerns (positive antibodies, goiter, symptoms, abnormal FT4) do not warrant specialist referral 4